High flow or titrated oxygen for obese medical inpatients: a randomised crossover trial.

CONCLUSION: High concentration oxygen therapy increases Ptco2 in morbidly obese patients. Our findings support guidelines that advocate oxygen therapy, if required in patients with morbid obesity, be titrated to achieve a target Spo2 of 88-92%. CLINICAL TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry, ACTRN12610000522011. PMID: 29129174 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/29129174?dopt=Abstract

Source: Medical Journal of Australia - November 15, 2017 Category: General Medicine Tags: Med J Aust Source Type: research